Anton M. Bennett PhD
Professor of Pharmacology and of Comparative Medicine; Co-Director, Program in Integrative Cell Signaling and Neurobiology of Metabolism; Director, BBS Minority Affairs
Departments & Organizations
Yale Combined Program in the Biological and Biomedical Sciences (BBS): Neuroscience | Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology
Interdepartmental Neuroscience Program
Stem Cell Center, Yale: Tissue Specific Stem Cells
Vascular Biology and Therapeutics Program
Comparative Medicine: Integrative Cell Signaling & Neurobiology of Metabolism (ICSNM)
Pharmacology: Neuropharmacology | Bennett Lab
Diabetes Endocrinology Research Center
Yale Core Center for Musculoskeletal Disorders
Signal transduction; Protein tyrosine phosphatases; Cancer; Diabetes; Obesity; Muscle stem cells; Muscular dystrophy more...
- Ph.D., New York Medical College, 1993
- Shi, H., Verma, M., Zhang, L. Dong, C., Flavell, R.A., and Bennett, A. M. (2013), Improved Regenerative Myogenesis and Muscular Dystrophy in Mice lacking MKP-5, J. Clin. Invest., 123: 2064-2077.
- Lawan, A., Shi, H., Gratzke, F. and Bennett, A.M. (2013) Diversity of mitogen-activated protein kinase phosphatase-1 functions, Cellular and Molecular Life Sciences (CMLS), 70:223-237.
- Mercan, F., Lee, H., Kolli, S. and Bennett, A. M. (2013) A Novel Role for SHP-2 in Nutrient-Responsive Control of S6 Kinase 1 Signaling, Mol. Cell Biol., 33: 293-306.